The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Result of Extraordinary General Meeting

21 Jun 2018 10:16

RNS Number : 1273S
Synthomer PLC
21 June 2018
 

LEI: 213800EHT3TI1KPQQJ56

 

Synthomer plc - Result of EGM

 

Synthomer plc announces that the resolution proposed at its Extraordinary General Meeting held earlier today to amend the Articles of Association to raise the borrowing restriction to £750 million was duly passed on a show of hands.

 

In compliance with paragraph 9.6.2R of the Listing Rules, the resolution passed at the Meeting has been submitted for filing at the National Storage Mechanism and is available for inspection on their website at www.morningstar.co.uk/NSM

 

Details of the proxy voting instructions, lodged prior to the meeting, are set out below:

 

For

Against

Discretion

Votes Withheld

Resolution Number and Description

Holders Voting

Votes

Holders Voting

Votes

Holders Voting

Votes

Holders Voting

Votes

RES: 001

To approve the amendment to Article 93 of the Company's Articles of Association

350

266,468,709

35

3,094,825

30

65,390

11

21,505

 

 

An abstention is not a vote in law and is not counted in the calculation of proportion of votes 'For' or 'Against' a resolution.

 

Number of shareholders - 2,679

Issued share capital - 339,880,769 Ordinary shares of 10p each

Number of votes per share - one

Number of proxies lodged - 418

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ROMFKDDDCBKKQAB

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.